Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TUCSON, Ariz.--(BUSINESS WIRE)--BioDirection, Inc., a developer of point-of-care brain injury screening and monitoring devices to separate minor head injuries from mild traumatic head injury, announced that it recently completed a $3.95 million Series A financing. Funds will be used to complete the miniaturization of the Company’s innovative biosensor test platform and position the company for an initial product launch later this year.
Help employers find you! Check out all the jobs and post your resume.
